Search

Search Results

• Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location

  Lynn R. Kohan, MD, Dalia Elmofty, MD, Israel Pena, MD, Chuanhong Liao, MS

  19-38

  01/01/2021

• Opioid utilization patterns among patients with cancer and non-cancer pain

  Catherine J. Datto, MD, MS, Yiqun Hu, MD, PhD, Eric Wittbrodt, PharmD, MPH, Perry G. Fine, MD

  11-18

  01/01/2019

• Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia

  Lucy Chen, MD, Michael Sein, MD, Trang Vo, BA, Shihab Amhmed, MD, Yi Zhang, MD, Kristin St Hilaire, BA, PhD, Mary Houghton, BA, Jianren Mao, MD, PhD

  383-393

  11/01/2014

• Opioid therapy for chronic pain: Physicians’ attitude and current practice patterns

  Lucy Chen, MD, Mary Houghton, BA, Lindsey Seefeld, BS, Charlene Malarick, BSN, RN, Jianren Mao, MD, PhD

  267-276

  01/15/2018

• Examining the relationship between pain interference, pain intensity, and mental health symptoms among veterans receiving long-term opioid therapy for chronic noncancer pain in primary care

  Amanda Kutz, PhD, Amber Martinson, PhD, Katherine Stratton, PsyD, Clayton Hamilton, PharmD, Julie Carney, RN, William Jacobson, RN, Katherine Sadler, RN, Tauna Thomas, RN, William Marchand, MD, Jamie Clinton-Lont, MS, CNP

  289-299

  07/01/2021

• Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers

  Robert N. Jamison, PhD, Kerry Anne Sheehan, BA, Elizabeth Scanlan, NP, Michele Matthews, PharmD, Edgar L. Ross, MD

  375-382

  11/01/2014
• 

  Buprenorphine: Opioid Agonist-Antagonist for Refractory Pain of Sickle Cell Disease Patients During Hematopoietic Stem Cell Transplant, Uncontrolled By Full-Agonist Opioids

  Mayuko Sakae, MD

  B14

  09/19/2024

• Analgesic treatment for moderate-to-severe acute pain in the United States: Patients’ perspectives in the Physicians Partnering Against Pain (P3) Survey

  Bruce L. Moskovitz, MD, Carmela J. Benson, MS, Aarti A. Patel, MBA, PharmD, Wing Chow, MPH, PharmD, Samir H. Mody, MBA, PharmD, Bill H. McCarberg, MD, Myoung S. Kim, MBA, MA, PhD

  277-286

  01/15/2018

• Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients

  Laxmaiah Manchikanti, MD, James Giordano, PhD, Mark V. Boswell, MD, PhD, Bert Fellows, MA, Rajeev Manchukonda, BDS, Vidyasagar Pampati, MSc

  89-100

  03/01/2007

• The prevalence of opioid medication use among adults in the United States

  Peter M. Mullins, MD, MA, MPH, Christopher J. Gilligan, MD, MBA, Neil Bhattacharyya, MD

  503-509

  11/01/2022

• Opioid use in young veterans

  Phipson C. Wu, PharmD, BCPS, Courtney Lang, PharmD, BCPS, Noelle K. Hasson, PharmD, Steven H. Linder, MD, David J. Clark, MD

  133-139

  01/29/2018

• Physician management of moderate-to-severe acute pain: Results from the Physicians Partnering Against Pain (P3) Study

  Bill H. McCarberg, MD, Aarti A. Patel, PharmD, MBA, Carmela J. Benson, MS, Samir H. Mody, PharmD, MBA, Wing Chow, PharmD, MPH, Carla L. Zema, PhD, Gary J. Vorsanger, PhD, MD, Myoung S. Kim, PhD, MBA, MA

  401-406

  11/01/2013

• Measuring opioid dependence in chronic pain patients: A comparison between addiction clinic and pain clinic patient populations

  Mike McDonough, MBBS, Jacinta L. Johnson, PhD, Jason M. White, PhD, Femke T. A. Buisman-Pijlman, PhD

  285-293

  07/01/2019

• How opioid prescribing policies influence primary care clinicians’ treatment decisions and conversations with patients with chronic pain

  Elizabeth C. Danielson, PhD, Christopher A. Harle, PhD, Sarah M. Downs, MPH, Laura Militello, MA, Olena Mazurenko, MD, PhD

  499-509

  11/01/2021

• Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: A national multifaceted assessment of physicians, pharmacists, and their patients

  Gregory D. Salinas, PhD, Debi Susalka, B. Stephen Burton, MS, Nancy Roepke, MBA, Kimberly Evanyo, David Biondi, DO, Susan Nicholson, MD

  273-284

  09/01/2012

• Clinical practice patterns of opioid prescribing by physicians performing percutaneous spinal cord stimulation trials and implants

  Keisha Dodman, MD, Thomas T. Simopoulos, MD, Lynn Kohan, MD, Jamal Hasoon, MD, Jatinder Gill, MD

  171-178

  03/01/2023

• How to wean friends and influence health: Opioid weaning and discontinuation aided by a simple health and wellness coaching program

  Heath B. McAnally, MD, MSPH, Stormie M. Thompson, DO, Paul Okediji, MBChB

  57-67

  01/01/2023

• Influence of prior opioid exposure on diagnostic facet joint nerve blocks

  Laxmaiah Manchikanti, MD, Mark V. Boswell, MD, PhD, Rajeev Manchukonda, BDS, Kimberly A. Cash, RT, James Giordano, PhD

  351-360

  01/30/2018

• Assessment of acute pain in trauma—A retrospective prehospital evaluation

  Stine Hebsgaard, MD, Anne Mannering, MD, Stine T. Zwisler, MD, PhD

  347-353

  09/01/2016

• More than half of opioids prescribed to pediatric patients after ambulatory knee surgery are unused

  Pamela Wendel, MD, Danya DeMeo, BS, Madison R. Heath, BS, Alexandra T. Mackie, BA, PB-BS, Haoyan Zhong, MPA, Kathryn DelPizzo, MD, Kanupriya Kumar, MD, Peter D. Fabricant, MD, MPH

  311-320

  07/01/2021

• Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force

  Lisa B. E. Shields, MD, Timothy A. Johnson, BS, Michael W. Daniels, MS, Alisha Bell, MSN, RN, CPN, Diane M. Siemens, PharmD, James T. Jennings, MD, MBA, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, MBA, FAAP

  155-167

  03/01/2021

• A qualitative study of chronic pain and opioid use: The impact of restrictive prescribing

  Cara L. Sedney, MD, MA, Patricia Dekeseredy, MScN, RN, Marissa Davis, BS, Treah Haggerty, MD, MS

  95-102

  10/18/2023

• Teaching clinical opioid pharmacology with the Human Patient Simulator

  Zaki Hassan, MD, Amy DiLorenzo, MA, Paul Sloan, MD

  125-132

  01/29/2018

• Academic family medicine physicians' confidence and comfort with opioid analgesic prescribing for patients with chronic nonmalignant pain

  Allison A. Macerollo, MD, Donald O. Mack, MD, Rupal Oza, MD, MPH, Ian M. Bennett, MD, PhD, Lorraine S. Wallace, PhD

  255-261

  07/01/2014

• Impact of continuous infusions of opioids on discharge opioid prescriptions

  Vincent Morocco, PharmD, BCPS, Jordan DeWitt, PharmD, BCPS, BCCCP, Angela Harding, PharmD, BCCCP, Jessica Geiger, PharmD, MS, BCPS, CPE, Shauna Ayres, MPH, CHES

  223-228

  05/05/2022

• Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC)

  Sohan Lal Solanki, MD, PDCC, MAMS, Raghu S. Thota, MD, MAMS, Jeson Rajan Doctor, MD, DNB, MNAMS, Gauri Raman Gangakhedkar, DNB, Parmanand Jain, MD, MAMS, Vijaya Gottumukkala, MD, Rakesh Garg, MD, Juan P. Cata, MD, Jyotsna Goswami, MD, Namrata Ranganath, MD, Seshadri Ramkiran, DA, DNB, Babita Ghai, MD, Keyuri U. Popat, MD, Donal J. Buggy, MD, Anjali A. Pingle, DNB, FRCA, Vaibhavi Baxi, DNB, Basanth Kumar Rayani, MD, Mary Thomas, DA, DNB, Sushma Bhatnagar, MD, Jigeeshu V. Divatia, MD, FCCM

  417-437

  09/01/2021

• An Acute Pain Service experience initiating methadone for opioid use disorder in hospitalized patients with acute pain

  Rebecca C. Dale, DO, Carol L. Metcalf, MN, ARNP, Dale J. Langford, Christina E. Bockman, PharmD, Debra B. Gordon, DNP, RN, FAAN, Daniel L. Krashin, MD, Katherin A. Peperzak, MD, Andrea K. Breuner, PA-C, Michelle C. Accardi-Ravid, PhD, Ivan K. Lesnik, MD

  275-283

  07/01/2019

• Patient engagement and prescription opioid use in perioperative pain management

  Anping Xie, PhD, Yea-Jen Hsu, PhD, Traci J. Speed, MD, PhD, Mariel Villanueva, BS, Irini Hanna, BS, David A. Slupek, MS, Jaclyn Nguyen, MS, Ronen Shechter, MD, Marie N. Hanna, MD, MEHP

  421-433

  09/01/2022

• Expectation-setting and patient education about pain control in the perioperative setting: A qualitative study

  Josh Bleicher, MD, MS, Jordan Esplin, BS, Allison N. Blumling, MS, Jessica N. Cohan, MD, MAS, Mark Savarise, MD, MBA, FACS, David W. Wetter, PhD, Alex H.S. Harris, PhD, MS, Kimberly A. Kaphingst, ScD, Lyen C. Huang, MD, MPH, FACS

  455-464

  11/01/2021

• Hypogonadism associated with long-term opioid therapy: A systematic review

  Pravardhan Birthi, MD, Vittal R. Nagar, MD, Robert Nickerson, MD, Paul A. Sloan, MD

  255-278

  05/01/2015

• Acute opioid withdrawal precipitated by ingestion of crushed Embeda (morphine extended release with sequestered naltrexone): Case report and the focused review of the literature

  Xiulu Ruan, MD, Tao Chen, MD, PhD, Jeff Gudin, MD, John Patrick Couch, MD, Srinivas Chiravuri, MD

  300-303

  01/29/2018

• Opioid rotation in patients with cancer: A review of the current literature

  Athina Vadalouca, MD, PhD, FIPP, Eleni Moka, MD, Erifilli Argyra, MD, PhD, Panayiota Sikioti, MD, Ioanna Siafaka, MD, PhD

  213-250

  01/30/2018

• A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain

  Mila Etropolski, MD, Bernd Lange, MD, MSc, Jutta Goldberg, PhD, Achim Steup, Dipl.-Stat., Christine Rauschkolb, MD, PhD

  343-356

  09/01/2013

• A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders

  Sarina R. Isenberg, MA, Allysha C. Maragh-Bass, MPH, PhD, Kathleen Ridgeway, MSPH, Mary Catherine Beach, MD, MPH, Amy R. Knowlton, MPH, ScD

  5-16

  01/01/2017

• Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol

  Andrew Rosenblum, PhD, Ricardo A. Cruciani, MD, PhD, Eric C. Strain, MD, Charles M. Cleland, PhD, Herman Joseph, PhD, Stephen Magura, PhD, CSW, Lisa A. Marsch, PhD, Laura F. McNicholas, MD, PhD, Seddon R. Savage, MD, MS, Arun Sundaram, BA, Russell K. Portenoy, MD

  11/01/2012

• Transdermal buprenorphine controls central neuropathic pain

  Michelle Weiner, DO, MPH

  414-415

  11/01/2012

• Postoperative surgical trainee opioid prescribing practices (POST-OPP): A national survey

  David J. Hall, MD, Juan C. Mira, MD, Melissa R. Hoffman, MD, ND, Hari B. Keshava, MD, MS, Kevin R. Olsen, MD, John C. Hardaway, MD, PhD, Patrick W. Underwood, MD, Kristy L. Hawley, MD, MPH, Patricia L. Turner, MD, Ajay B. Antony, MD, Terrie Vasilopoulos, PhD, Nicolas J. Mouawad, MD, MPH, MBA

  307-322

  07/01/2019

• A history of opioid abuse: Why buprenorphine is superior for the management of opioid use disorder and pain

  Michael D. Komrowski, MS, Nitin K. Sekhri, MD

  43-50

  08/01/2021

• Educational intervention for physicians to address the risk of opioid abuse

  Margaret K. Pasquale, PhD, Richard L. Sheer, BA, Jack Mardekian, PhD, Elizabeth T. Masters, MS, MPH, Nick C. Patel, PharmD, PhD, Amy R. Hurwitch, PharmD, BCPS, Jennifer J. Weber, PharmD, MS, BCPS, CGP, BCACP, Anamaria Jorga, MD, Carl L. Roland, PharmD, MS

  303-313

  09/01/2017

• Association of transdermal fentanyl and oral transmucosal fentanyl citrate in the treatment of opioid naïve patients with severe chronic noncancer pain

  Francisco Collado, MD, PhD, Luis M. Torres, MD, PhD

  111-115

  01/30/2018

• Do pain specialists meet the needs of the referring physician? A survey of primary care providers

  Jane R. Wilkens, MD, Miles J. Belgrade, MD

  13-20

  01/30/2018

• Use of a comprehensive survey as a first step in addressing clinical competence of physicians-in-training in the management of pain

  Mark Chaitowitz, MBBCh, William Tester, MD, Glenn Eiger, MD

  98-108

  05/01/2005

• The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain

  Richard L. Rauck, MD, Stephen A. Bookbinder, MD, Timothy R. Bunker, MD, Christopher D. Alftine, MD, Richard Ghalie, MD, Andres Negro-Vilar, MD, PhD, Egbert de Jong, MD, Steven Gershon, MD

  155-166

  05/01/2006

• Identifying predictors of opioid use among older United States’ adults with pain

  David Rhys Axon, PhD, MPharm, MS, Marion Slack, PhD, Terri Warholak, PhD, RPh, FAPhA, CPHQ

  95-105

  03/01/2022

• New legislation in New Jersey reduced opioid use among trauma patients

  Renay Durling-Grover, DNP, APN, Louis T. DiFazio, MD, FACS, John M. Adams, MD, FACS, Karen Kong, BS, Sara S. Soliman, BS, Daniel Hakakian, BS, Keren Kaynan, BS, Rolando H. Rolandelli, MD, FACS, Zoltan H. Nemeth, MD, PhD

  133-137

  03/01/2023

• Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing?

  Jean C. McCalmont, DNP, FNP, Kim D. Jones, PhD, FNP, FAAN, Robert M. Bennett, MD, FRCP, MACR, Ronald Friend, PhD

  103-116

  03/01/2018

• Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System

  Lauren Hundley, PharmD, BCPS, Shelley Spradley, PharmD, BCPS, Scott Donelenko, BPharm, CPE

  89-101

  03/01/2018

• Opioid prescription patterns in a children's hospital from 2012 to 2016

  Nicole Titze, MD, Rishi Bhargava, MD, Ara Jamasbi Montalvo, MD, Gawon Shin, BA, Campbell Belisle Haley, MD, Soheil Saadat, MD, MPH, PhD, Bharath Chakravarthy, MD, MPH

  489-494

  12/19/2023

• Harnessing endogenous opioids for pain relief: Fantasy vs reality

  Alan R. Gintzler, PhD, Nai-Jiang Liu, MD, PhD

  67-72

  01/01/2020
• 

  Post-operative pain control in patients on buprenorphine or methadone for opioid use disorder

  Aurora Quaye, MD, Tal Tsafnat, BA, MS, Janelle M. Richard, BA, Henry Stoddard, MPH, David J. Gagnon, PharmD

  233-241

  05/01/2024

• Select practice behaviors of clinicians on the use of opioids for adolescents with subacute and chronic nonmalignant pain

  John M. Saroyan, MD, Wendy Y. Cheng, MPH, Damani C. Taylor, BA, Amna Afzal, MD, Nomita Sonty, MPhil, PhD, Maria A. Sullivan, MD, PhD

  123-134

  01/15/2018

• Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature

  Valerie Hruschak, MSW, Gerald Cochran, PhD, Ajay D. Wasan, MD, MSc

  345-358

  09/01/2018

• Ultra-low-dose opioid antagonists to enhance opioid analgesia

  Paul Sloan, MD, Scott Hamann, PhD, MD

  295-304

  09/01/2006

• Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review

  Paul Alexander Sloan, MD, Robert L. Barkin, PharmD, MBA

  131-144

  01/30/2018

• Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management

  Aarti Singla, MD, Paul Sloan, MD

  71-80

  01/01/2013

• Discussions between patients with chronic pain and their primary care provider about opioids and pain relief during routine clinic encounters

  Mayra Massey, MMFT, Carissa Carissa van den Berk Clark, PhD, MSW, Jocelyn Fowler, MMFT, Jeffrey F. Scherrer, PhD

  137-146

  03/01/2019

• Physician-related barriers to cancer pain management with opioid analgesics: A systematic review

  Ramune Jacobsen, MS, MPH, Per Sjøgren, MD, DMS, Claus Møldrup, PhD, Lona Christrup, PhD

  207-214

  07/01/2007

• Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol

  Andrew Rosenblum, PhD, Ricardo A. Cruciani, MD, PhD, Eric C. Strain, MD, Charles M. Cleland, PhD, Herman Joseph, PhD, Stephen Magura, PhD, CSW, Lisa A. Marsch, PhD, Laura F. McNicholas, MD, PhD, Seddon R. Savage, MD, MS, Arun Sundaram, BA, Russell K. Portenoy, MD

  369-382

  11/01/2012

• Implementation of a collaborative care management program with buprenorphine in primary care: A comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically

  Joji Suzuki, MD, Michele L. Matthews, PharmD, David Brick, BA, Minh-Thuy Nguyen, Robert N. N. Jamison, PhD, Andrew L. Ellner, MD, MSc, Lori W. Tishler, MD, Roger D. Weiss, MD

  159-168

  05/01/2014

• Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study

  Jesús González-Barboteo, MD, Xavier Gómez-Batiste Alentorn, MD, PhD, Felipe A. Calvo Manuel, MD, PhD, Vicente Alberola Candel, MD, M. Amalia Palacios Eito, MD, Isabel Sánchez-Magro, MD, PhD, F. Javier Pérez Martín, PhD, Josep Porta-Sales, MD, PhD

  395-403

  11/01/2014

• Physician survey examining the impact of an educational tool for responsible opioid prescribing

  Aaron Young, PhD, Kelly C. Alfred, MS, Philip P. Davignon, MA, LaSharn M. Hughes, MBA, Lisa A. Robin, MLA, Humayun J. Chaudhry, DO

  81-87

  03/01/2012

• The role of transdermal compounding in opioid safety

  Caitlin V. Bucher, PharmD, A.J. Day, PharmD, Maria Carvalho, PhD

  17-22

  03/05/2018

• Opioid-induced hyperalgesia: Pathophysiology and clinical implications

  Sukanya Mitra, MD, MAMS

  123-130

  01/30/2018

• Chronic opioid therapy issues associated with opioid abuse potential

  Howard S. Smith, MD, Kenneth L. Kirsh, PhD, Steven D. Passik, PhD

  287-300

  01/29/2018

• Role of patient-based health status outcome measurements in opioid management for low back pain

  Vinod K. Podichetty, MD, MS, Eric S. Varley, DO, Michelle Secic, MS

  153-162

  01/30/2018
• 

  Claims data analysis of provider-to-provider tele-mentoring program impact on opioid prescribing in Missouri

  Olabode B. Ogundele, MS, Xing Song, PhD, Praveen Rao, PhD, Tracy Greever-Rice, PhD, Suzanne A. Boren, PhD, Karen Edison, MD, Douglas Burgess, MD, Mirna Becevic, PhD

  133-147

  04/01/2024

• Predictors of opioid prescription among outpatients with osteoarthritis in the United States

  Shrey Gohil, BPharm, Niaz Deyhim, PharmD, MS, BCPS, Osaro Mgbere, PhD, MS, MPH, Ekere James Essien, MD, DrPH, FRSPH

  205-223

  04/19/2023

• Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management

  Peter Holzer, PhD, Sam H. Ahmedzai, BSc, MBChB, FRCP, Norbert Niederle, MD, Petra Leyendecker, PhD, Michael Hopp, MD, Björn Bosse, Statistics (Diploma), Ingrid Spohr, PhD, Karen Reimer, MD

  145-151

  01/29/2018

• Effectiveness and tolerability of tapentadol sustained release in the Australian setting

  Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA, Danielle M. Santarelli, PhD

  187-196

  05/01/2016

• Extended-Release and Long-Acting Opioids for Chronic Pain Management

  Paul A. Sloan, MD, Mellar P. Davis, MD, FCCP

  05/04/2023

• Physicians’ interest in different strategies for supporting pain management and opioid prescribing: A cross-sectional study

  Marcia G. Ory, PhD, Shinduk Lee, DrPH, Deborah Vollmer Dahlke, DrPH, Nicole Pardo, MD, Lixian Zhong, PhD, Carly E. McCord, PhD, Joy P. Alonzo, PharmD, Matthew Lee Smith, PhD

  511-521

  11/01/2022

• Perioperative substance use disorder, opioid diversion, and opioid misuse by a medical professional undergoing orthopedic surgery

  Dermot Maher, MD, MS, Michael Kissen, MD, Itai Danovitch, MD, MBA, Roya Yumul, MD, PhD, Charles Louy, PhD, MD

  437-440

  11/01/2014

• Factors that impact initiation of pain management agreements for patients on chronic opioid therapy

  Katherine Gonzalez, BS, Alejandro Villasante-Tezanos, PhD, Gulshan Sharma, MD, MPH, Gulshan Doulatram, MD, Stephen B. Williams, MD, MS, Erin L. Hommel, MD

  423-431

  11/20/2023

• A qualitative study to develop materials educating patients about opioid use before and after total hip or total knee arthroplasty

  David H. Smith, PhD, RPh, Jennifer Kuntz, PhD, Lynn DeBar, PhD, Jill Mesa, Xiuhai Yang, MS, David Boardman, MD, Jennifer Schneider, MPH

  183-190

  07/02/2018

• Aberrant behaviors in a primary care-based cohort of patients with chronic pain identified as misusing prescription opioids

  Martin D. Cheatle, PhD, Charles P. O’Brien, MD, PhD, Koshy Mathai, MD, Matthew Hansen, MD, Mario Grasso, MD, Peter Yi, MD

  315-324

  09/01/2013

• Definitive urine drug test findings in patients prescribed opioids for pain from a large national database

  Maria G. Guevara, PharmD, CPE, Leah LaRue, PharmD, CMPP, PMP, Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP, Penn Whitley, MS, Eric Dawson, PharmD, Steven D. Passik, PhD

  361-375

  07/01/2022

• Potential impact of abrupt opioid therapy discontinuation in the management of chronic pain: A pilot study on patient perspective

  Joy Hao, MD, PhD, David Lucido, PhD, Ricardo A. Cruciani, MD, PhD

  9-20

  01/01/2014

• Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting

  James Brown, MD, Beatrice Setnik, PhD, Keung Lee, MD, PhD, Linda Wase, MD, Carl L. Roland, PharmD, Jody M. Cleveland, MS, Sherry Siegel, MD, Nathaniel Katz, MD, MS

  467-483

  11/01/2017

• National gender differences in the prescribing of opioid medications from 2006 to 2015

  Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD

  197-208

  05/01/2020

• Clinician opioid prescribing practices and patient utilization of prescribed opioids in pediatrics

  Jeannie S. Huang, MD, MPH, Cynthia L. Kuelbs, MD

  309-316

  09/01/2018

• An evaluation of the performance of the Opioid Manager clinical tool in primary care: A qualitative study

  Andrew Robertson, BSc, MD (Candidate), Sander L. Hitzig, PhD, Andrea D. Furlan, MD, PhD

  187-199

  05/01/2014

• Cancer pain in the opioid-addicted patient: Can we treat it right?

  Vania Modesto-Lowe, MD, MPH, Lisa Girard, BS, MHS, PA-C, Margaret Chaplin, MD

  167-175

  05/01/2012
• 

  Conversion of CII Opioid Medications to Buprenorphine in the Chronic Pain Population - Insights and Clinical Pearls

  Amanda Zimmerman, PA-C

  B11

  09/11/2024

• Association of request for opioid medications refill after hospital discharge with race in patients with prostate cancer treated with robotic-assisted laparoscopic radical prostatectomy

  Shaheen Alanee, MD, Diana Chammout, Mustafa Deebajah, MD, James Peabody, Mani Menon

  447-453

  09/01/2022

• Perceived patient benefits from using prescription opioids and other therapies to manage persistent pain

  Farzana Mitra, MD, MBBS, FRACGP, DA, Dip. AC, Torres Woolley, PhD, MPHTM

  5-14

  01/01/2020

• The effect of the COVID-19 pandemic on opioid prescribing for patients with pleuritic pain

  Andrew Ormsby, MD, Caitlin Dietsche, MD

  529-535

  11/01/2022

• Retrospective study of the effect of opioid prescribing guidelines on prescribing practices in pediatric orthopedic sports medicine patients having knee surgery: A single institution's experience

  Jeffrey G. Stepan, MD, MSc, Christine Goodbody, MD, Kanupriya Kumar, MD, Kathryn DelPizzo, MD, Peter Fabricant, MD, MPH, Pamela Wendel, MD

  284-288

  07/01/2021

• Shifting quality chronic pain treatment measures from processes to outcomes

  Christa Coleman, PsyD, MSCP, Robert P. Lennon, MD, JD, Rose Hennessy Garza, PhD, MPH, Christin Veasley, BS, Jay Kuchera, MD, Robert Edwards, PhD, Aleksandra E. Zgierska, MD, PhD

  83-94

  10/18/2023

• Opioid prescribing knowledge and practices: Provider survey following promulgation of guidelines–Utah, 2011

  Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD

  217—224

  05/01/2013

• Limited use of nonopioid analgesics after pediatric ambulatory surgery

  Nhi Ho, MD, Anjali A. Dixit, MD, MPH, Christina Inglis-Arkell, MD, Solmaz P. Manuel, MD

  101-107

  03/01/2021

• Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain

  Lisa R. Witkin, MD, Dina Diskina, BS, Shawn Fernandes, BS, John T. Farrar, MD, PhD, Michael A. Ashburn, MD, MPH

  177—187

  05/01/2013

• Assessment of post-operative opioid prescribing practices in a community hospital ambulatory surgical center

  Warren D. Bromberg, MD, FACS, Tracey Emanuel, MSN, RN, FNP-BC, Valerie Zeller, MA, RN, Elizabeth Galloway, BSN, RN, CAPA, Susan Mogan, DNP, ANP-BC, ACHPN, AP-PMN, Justin Diamond, BS, Debra Statler, RN III-C, BC, Fay Wright, PhD, RN, APRN-BC

  241-249

  07/19/2021

• Opioid epidemics during the pandemic: Further insights to the same story

  Amany E. Ayad, MD, FIPP

  9-12

  01/01/2021

• Review of perioperative pain management of opioid-dependent patients

  Nalini Vadivelu, MD, Sukanya Mitra, MD, MAMS, Alice M. Kai, BA, Gopal Kodumudi, MS, Karina Gritsenko, MD

  289-301

  07/01/2016

• Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey

  Shaloo Gupta, MS, Haridarshan Patel, PharmD, Justin Scopel, MD, MBA, Reema R. Mody, MBA, PhD

  325-338

  07/01/2015

• Preliminary data on a new opioid risk assessment measure: The Brief Risk Interview

  Ted Jones, PhD, Todd Moore, PhD

  19-27

  01/01/2013

• Developing opioid prescribing recommendations in the postoperative orthopedic setting

  Daniel K. Haddad, PharmD, Orrin H. Sherman, MD

  333-341

  07/01/2019
• 

  A pilot study to examine the opioid prescribing practices of medical residents

  Nathaniel J. Leavitt, DO, Rachel S. Sundman, DO, Matthew White, DO, Johannie M. Spaan, PhD, Belinda McCully, PhD, Glen E. Kisby, PhD

  487-494

  12/01/2024

• Survey of opioid tapering practices of pediatric healthcare providers: A national perspective

  Deborah Fisher, PhD, RN, PPCNP-BC, Suzanne W. Ameringer, PhD, RN

  59-64

  01/01/2017

• Opioid contract use is associated with physician training level and practice specialty

  Bryan Keith Touchet, MD, William Robert Yates, MD, Kim Annette Coon, EdD

  195-200

  09/01/2005

• Perioperative management of opioid-tolerant chronic pain patients

  Dima Rozen, MD, Noah P. DeGaetano, MD

  353-363

  11/01/2006

• Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain

  Lynn Webster, MD, Barbara St. Marie, NP, Bill McCarberg, MD, Steven D. Passik, PhD, Sunil J. Panchal, MD, Eric Voth, MD

  235-245

  01/15/2018

• Communication between nurse care managers and patients who take opioids for chronic pain: Strategies for exploring aberrant behavior

  Jane M. Liebschutz, MD, MPH, Allison V. Lange, MD, Orlaith D. Heymann, MA, Karen E. Lasser, MD, MPH, Pamela Corey, MSN, EdD, RN, CHSE, Christopher W. Shanahan, MD, MPH, Hannah S. Kopinski, BA, Jawad M. Husain, MD, Phoebe A. Cushman, MD, MS, Victoria A. Parker, EdM, DBA

  191-202

  07/02/2018

• Assessing coprescription of opioids with central nervous system depressants for nonmalignant chronic musculoskeletal pain management in the outpatient setting

  Rana Zalmai, PharmD, Walter Agbor Bawa, PharmD, Meredith Howard, PharmD, Rafia S. Rasu, PhD

  107-122

  03/01/2022

• A model for an institutional response to the opioid crisis

  Marie N. Hanna, MD, MEHP, Chester Chambers, PhD, Ananth Punyala, MS, Asniya Iqbal, MS, Bhuchitra Singh, MD, MPH, MS, Cagla Oruc, MS, Priyamvadha Prakash, MS, Yash Prajapati, MS, Yidong Wang, MS, Zeyu Amery Ai, MS, Ronen Shechter, MD, Traci J. Speed, MD, PhD, Colleen G. Koch, MD, MS, MBA, Kayode Williams, MD, MBA

  73-83

  01/01/2020
• 

  Buprenorphine: An anesthesia-centric review

  Thomas Hickey, MD, MS, Gregory Acampora, MD

  503-527

  12/01/2024

• A more balanced approach to opioid use and management is also needed in end-of-life care

  Sydney Morss Dy, MD, MSc, Cynda Hylton Rushton, PhD, RN, FAAN

  371-373

  11/01/2016
• 

  Clinical Pharmacist with DEA License: Efforts to Increase Access to Buprenorphine in a Veteran Population

  Shelley Stevens, PharmD, BCPS

  B02

  09/03/2024

• A review of epidural and intrathecal opioids used in the management of postoperative pain

  Borja Mugabure Bujedo, MD, Silvia González Santos, MD, Amaia Uría Azpiazu, MD

  177-192

  05/01/2012
• 

  Effectiveness of a discharge analgesia guideline on discharge opioid prescribing after a surgical procedure from a tertiary metropolitan hospital

  Katelyn Jauregui, BPharm (Hons), Shania Liu, BPharm (Hons), PhD, FSHP, Asad Patanwala, PharmD, MPH, FASHP, FCCP, David Begley, BN, GradCertPainMgt, GradCertIntCare, Kok Eng Khor, MBBS, MM(PM), DipMSM, GDAdMeHlt, Bernadette Bugeja, BN, MN (AdClinEd), Ian Fong, BPharm (Hons), Joanne Rimington, BPharm, Jonathan Penm, BPharm (Hons), GradCertEdStud (Higher Ed), PhD

  329-338

  08/01/2024

• Health disparities in ethnic and racial minority populations with pain and opioid use disorder

  Heather DeBruin, BSN Student, Barbara J. St. Marie, PhD, AGPCNP, FAANP, FAAN

  23-36

  10/18/2023

• Addressing the opioid crisis: An assessment of clinicians’ training experience, practices, and attitudes within a large healthcare organization

  Harshal Kirane, MD, Elina Drits, DO, Seungjun Ahn, MS, Sandeep Kapoor, MD, Jonathan Morgenstern, PhD, Joseph Conigliaro, MD, Jay Enden, MD

  193-204

  05/01/2019

• A multifactorial intervention for hospital opioid management

  Mehmet Akce, MD, Anupam Suneja, MD, Cheryl Genord, RPh, Bonita Singal, MD, PhD, John A. Hopper, MD

  337-344

  09/01/2014

• Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care—The HARMS Program: A retrospective chart review of 77 patients

  Niharika Shahi, HBSc, Ryan Patchett-Marble, BSc, MD, CCFP(AM)

  277-282

  07/01/2020

• Defining clinical issues around tolerance, hyperalgesia, and addiction: A quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice

  Jennifer P. Schneider, MD, PhD, Kenneth L. Kirsh, PhD

  385-395

  01/29/2018

• Improving use of narcotics for nonmalignant chronic pain: A lesson from Community Care of North Carolina

  Ed Bujold, MD, FAAFP, Jessica Huff, MPH, Elizabeth W. Staton, MSTC, Wilson D. Pace, MD, FAAFP

  363-367

  11/01/2012

• Primary care physicians’ perspectives on Veterans who obtain prescription opioids from multiple healthcare systems

  Felicia R. Bixler, MS, Thomas R. Radomski, MD, MS, Susan L. Zickmund, PhD, KatieLynn M. Roman, BA, Leslie R. M. Hausmann, PhD, Carolyn T. Thorpe, PhD, MPH, Jennifer A. Hale, BS, Florentina E. Sileanu, MS, Walid F. Gellad, MD, MPH

  183-191

  05/01/2019

• Perioperative gabapentinoid use lowers short-term opioid consumption following lower limb arthroplasty: Systematic review and meta-analysis

  Ryan Campbell, MD, Jacqueline Nguyen Khuong, MD, Zhengyang Liu, BBiomed, Carla Borg, MD, Sarah Jackson, BBiomed, Dhruvesh M. Ramson, MBBS (Hons), Juliana Kok, MD, Ned Douglas, MD, Jahan C. Penny-Dimri, MBBS (Hons), Luke A. Perry, MBBS (Hons)

  251-272

  07/19/2021

• Pharmacy multidisciplinary stewardship program for high-risk patients prescribed opioids in an academic clinic

  Yvette Hellier, PharmD, Machelle Wilson, PhD, Angela Leahy, PharmD, Kevin Burnham, MD

  341-350

  09/01/2020

• Factors associated with heroin use among those reporting prescription opioid misuse: Results from a nationally representative sample

  A. Taylor Thomas, MD, MPH, Kara G. Fields, MS, Alan D. Kaye, MD, PhD, Richard D. Urman, MD, MBA

  243-255

  05/05/2022

• Quantification of oxycodone and morphine analytes in urine: Assessment of adherence

  Michael E. M. Larson, PhD, Richard L. Berg, MS, Joyce Flanagan, PhD

  489-500

  11/01/2015

• Potential innovative targets in the treatment of pain: Combined μ and NOP receptor agonists

  Raphael J. Leo, MA, MD

  277-283

  07/01/2021

• The emerging therapeutic roles of κ-opioid agonists

  Mark R. Jones, MD, Alan David Kaye, MD, PhD, Aaron J. Kaye, BA, Richard D. Urman, MD, MBA

  101-107

  03/01/2016

• Primary care providers’ prescribing practices of opioid controlled substances

  Lisa B. E. Shields, MD, Soraya Nasraty, MD, MMM, CPE, Alisha D. Bell, MSN, RN, CPN, Anil N. Vinayakan, MD, Raghunath S. Gudibanda, MD, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, FAAP

  397-403

  11/01/2016

• Implementation of required sedation assessment in nursing workflow to address naloxone utilization

  Edward Hardison, MD, Ainsley Bloomer, MD, Meghan K. Wally, PhD, Erica McArthur, MD, Joseph R. Hsu, MD, Susan Bear, PharmD, Steven Jarrett, PharmD, Tamar Roomian, MS, MPH, D. Matthew Sullivan, MD, Karon Wold, MSN, Ziqing Yu, MS, Susan Odum, PhD, Rachel B. Seymour, PhD

  247-255

  04/19/2023

• Tapering off long-term methadone: A case study

  Kehua Zhou, MD, DPT, LAc, Leslie Frankish, BS, Gary G. Wang, MD, PhD

  345-348

  07/01/2019

• The endocrine effects of long-term oral opioid therapy: A case report and review of the literature

  Jennifer A. Elliott, MD, Erica Horton, DO, Eugene E. Fibuch, MD

  145-154

  01/15/2018

• Telehealth acceptability and opioid prescribing patterns of providers of painful chronic diseases during the COVID-19 pandemic: A survey of sickle cell providers

  Martha O. Kenney, MD, Benjamin Becerra, DrPH; MBA, MPH, MS, Sean Alexander Beatty, BA, Wally R. Smith, MD

  489-497

  11/01/2021

• Opioid rotation: A case example using methadone in spinal cord injury

  Jayne Pawasauskas, PharmD, BCPS

  443-448

  09/01/2015

• A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain

  Samir Arora, MD, Beatrice Setnik, PhD, Michael Drass, MD, John D. Hudson, MD, Ray Clemmer, MS, Paul Meisner, PharmD, Glenn C. Pixton, MS, Veeraindar Goli, MD, Kenneth W. Sommerville, MD

  423-436

  11/01/2014

• Choosing the right laboratory: A review of clinical and forensic toxicology services for urine drug testing in pain management

  Gary M. Reisfield, MD, Bruce A. Goldberger, PhD, Roger L. Bertholf, PhD

  01/01/2015

• Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders

  S. Geoff Severtson, PhD, Marie C. Gurrola, MPH, Mark W. Parrino, MPA, Matthew S. Ellis, PhD, MPE, Theodore J. Cicero, PhD, Janetta L. Iwanicki, MD, Richard C. Dart, MD, PhD

  445-453

  11/20/2023

• Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusio

  Bethany W. Ibach, PharmD, Carol Loeber, MSN, APRN-CNP, Mohanad Shukry, MD, Tracy M. Hagemann, PharmD, FCCP, FPPAG, Donald Harrison, PhD, FAPhA, Peter N. Johnson, PharmD, BCPS

  295-303

  07/01/2015

• Postoperative pain scores and opioid consumption in opioid-dependent patients with cancer after intraoperative remifentanil analgesia: A prospective case-controlled study

  Cyrus Motamed, MD, Juliette Audibert, MD, Aline Albi-Feldzer, MD, Gaelle Bouroche, MD, Christian Jayr, MD, PhD

  221-228

  07/01/2017

• Letter to the editor. Mehendale Aw, Goldman MP, Mehendale RP: OPIOID Overuse Pain Syndrome (Oops): The story of opioids, Prometheus unbound. J Opioid Manag. 2013; 9(6): 421-438.

  Laxmaiah Manchikanti, MD, Sairam Atluri, MD, Mark V. Boswell, MD, PhD, Hans C. Hansen, MD, Anand Mehendale, MD, Mark P. Goldman, PhD, Rachel P. Mehendale, BA

  81-82

  03/01/2014

• Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline

  Josiah S. Morse, MPH, Hal Stockbridge, MD, MPH, Kathleen B. Egan, MPH, Jaymie Mai, PharmD, Thomas Wickizer, PhD, Gary M. Franklin, MD, MPH

  427-433

  11/01/2017

• Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey

  Timothy Bell, MHA, Kathy Annunziata, MA, John B. Leslie, MD, MBA

  137-144

  01/29/2018

• Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence

  Charles E. Argoff, MD, Meldon Kahan, MD, Edward M. Sellers, MD

  119-134

  03/01/2014

• Opioid therapy in children and adolescents: A physician's guide to risk assessment, monitoring, and mitigation of abuse

  Jessica Anne George, MD, Sabine Kost-Byerly, MD, Constance L. Monitto, MD

  357-368

  09/01/2013